START Midwest, LLC

Grand Rapids, Michigan 49546

8 studies enrolling now · 9 studies all time

What they study most

Advanced Breast Cancer, Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors, Advanced Solid Tumor, Advanced Solid Tumors, Breast Cancer, Colorectal Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Metastatic Colorectal Adenocarcinoma, Metastatic Prostate Cancer

Studies at this site

• Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors — Recruiting now
• A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms — Recruiting now
• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
• A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors — Recruiting now
• A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer — Recruiting now
• A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors — Recruiting now
• Study of HLD-0915 in Patients With Metastatic Prostate Cancer — Recruiting now
• First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors — Starting soon
• A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors — Completed